Estimates Revisions Genmab A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 04:53:01 11/12/2025 pm IST			5-day change	1st Jan Change
2,007.00 ^DKK	+0.78%		-2.86%	+34.20%

10/12	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT
09/12	Genmab shares encouraging early-stage data on epcoritamab for RT patients	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	GENMAB A/S
	ARGENX SE
	INSMED INCORPORATED
	WUXI APPTEC CO., LTD.
	BIONTECH SE
	WUXI BIOLOGICS (CAYMAN) INC.
	AKESO, INC.
	SUMMIT THERAPEUTICS INC.
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	MADRIGAL PHARMACEUTICALS, INC.
	Average
	Weighted average by Cap.